Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.
We thank Monneret and Bonnefont-Rousselot for their commentary. Our controlled trial design overcomes most of their concerns of course; any failure of assay techniques would not have produced a biased result, but in fact would have decreased the chances of finding any between-group effects. In our s...
Príomhchruthaitheoirí: | , , , |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
European Respiratory Society
2016
|